نتایج جستجو برای: nicosulfuron rimsulfuron 80 25 g aiha

تعداد نتایج: 938357  

Journal: :Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie 2014
Abdulgabar Salama Dirk Hartnack Hans-Walter Lindemann Hans-Joachim Lange Mathias Rummel Andreas Loew

BACKGROUND Many patients with autoimmune hemolytic anemia (AIHA) do not respond to standard therapy and/or may develop severe complications which can be of fatal outcome. There is some evidence that erythropoiesis-stimulating agents (ESAs) may be helpful in the management of such patients. METHODS We describe the effect of ESAs in 12 new patients with therapy-refractory AIHA (7 of warm type a...

2016
Andrea M. McGonigle Paul M. Ness Karen E. King

The hallmark of the autoimmune hemolytic anemias (AIHAs) and paroxysmal nocturnal hemoglobinuria (PNH) is shortened red blood cell survival. Although AIHA and PNH share the critical feature of shortened red cell survival, the mechanisms underlying this characteristic differ significantly between the two diseases. In the case of AIHA, autoantibodies directed against the patient’s own red blood c...

Journal: :Haematologica 1995
R Martino E Muñiz-Díaz M Arilla M Ibáñez A Altés C Guanyabens P Madoz

BACKGROUND Autoimmune neutropenia (AIN) can occur in association with autoimmune hemolytic anemia (AIHA) and/or immune thrombocytopenic purpura (ITP), although these associations have not been studied in detail. METHODS AND RESULTS Twenty cases of AIN were found in a group of 55 adults with unexplained neutropenia over a five-year period. Eight subjects with AIN had an associated AIHA and/or ...

2011
Jorge M. Hurtado-Cordovi Vaibhav Verma Vladimir Gotlieb Marianne Frieri

Hodgkin's lymphoma accounts for ten percent of all lymphomas. In the United States, there are about 8000 new cases every year. This paper describes a case of lymphocyte-rich Hodgkin's lymphoma (LRHL) manifested by autoimmune hemolytic anemia (AIHA). A 27-year-old Israeli male presented with dizziness associated with one month of low-grade fevers and night sweats; he also complained of persisten...

Journal: :Weed Technology 2022

Abstract Owing to the lack of effective POST herbicide options, producers typically rely on nicosulfuron as main grass in sweet corn production systems. In 2019, a Wisconsin producer reported fall panicum control escapes after spraying nicosulfuron. Seeds from mature plants were collected (1) measure response acetolactate synthase (ALS)-inhibiting herbicides, (2) elucidate resistance mechanism,...

2013
Peyman Naji Geetika Kumar Shabana Dewani William A. Diedrich Ankur Gupta

Graves' disease (GD) is associated with various hematologic abnormalities but pancytopenia and autoimmune hemolytic anemia (AIHA) are reported very rarely. Herein, we report a patient with GD who had both of these rare complications at different time intervals, along with a review of the related literature. The patient was a 70-year-old man who, during a hospitalization, was also noted to have ...

2017
Ljiljana Šantrić Ljiljana Radivojević Jelena Gajić Umiljendić Marija Sarić-Krsmanović

This study was conducted under laboratory conditions to investigate the effects of herbicides (nicosulfuron, metribuzin and glyphosate) on the number of actinomycetes in soil and growth of several isolates of actinomycetes in vitro. The lowest tested concentrations equalled the recommended rates (1X), while the other three were five-fold (5X), ten-fold (10X) and fifty-fold (50X). Samples were c...

Journal: :Haematologica 2004
J G Erdozain G Ruiz-Irastorza M V Egurbide C Aguirre

Standard treatment for autoimmune hemolytic anemia (AIHA) due to warm antibodies includes combinations of glucocorticoids, immunosuppressive drugs (mainly azathioprine) and splenectomy. Patients who are refractory or intolerant to these therapies constitute an important therapeutic challenge. Rituximab, an anti-CD20 chimeric monoclonal antibody, can effectively deplete B-cells and is commonly u...

Journal: :Internal medicine 2015
Yukinori Harada Hiroaki Yamamoto Midori Sato Mutsuki Kodaira Tsunesuke Kono

Adalimumab is commonly used to treat autoimmune diseases with few reported hematological adverse reactions. We herein describe the case of an 85-year-old Japanese man with plaque psoriasis who developed autoimmune hemolytic anemia (AIHA) after 3 years of adalimumab treatment. The patient suddenly developed hematuria and dyspnea on exertion while receiving adalimumab treatment. Laboratory data s...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید